日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Durable Response to Glofitamab in HIV-Positive Refractory Burkitt Lymphoma: Case Report and Discussion

HIV阳性难治性伯基特淋巴瘤患者对Glofitamab治疗的持久反应:病例报告及讨论

Elisa, Bozzotto; Theresa, Magnes; Dominik, Kiem; Barbara, Zellinger; Daniel, Neureiter; Arno, Beer; Alexander, Egle; Thomas, Melchardt

Durvalumab Is Associated with Prolonged Progression-Free Survival, While Concomitant Chemoradiotherapy May Improve Both Locoregional and Local Control in Elderly Patients with Unresectable NSCLC Stage III: Subanalysis of the Austrian Radio-Oncological Lung Cancer Study Association Registry (ALLSTAR)

Durvalumab 与延长无进展生存期相关,同时放化疗可改善老年不可切除 NSCLC III 期患者的局部区域控制和局部控制:奥地利放射肿瘤肺癌研究协会登记处 (ALLSTAR) 的亚组分析

Zehentmayr, Franz; Karner, Josef; Stana, Markus; Ruznic, Elvis; Zellinger, Barbara; Klebermass, Marisa; Purevdorj, Ayurzana; Gruber, Georg; Minasch, Danijela; Heilmann, Martin; Moosbrugger, Raphaela; Roeder, Falk; Grambozov, Brane

Delta Changes in [(18)F]FDG PET/CT Parameters Can Prognosticate Clinical Outcomes in Recurrent NSCLC Patients Who Have Undergone Reirradiation-Chemoimmunotherapy

[(18)F]FDG PET/CT 参数的变化可预测接受再放化疗免疫治疗的复发性非小细胞肺癌患者的临床预后

Grambozov, Brane; Zamani-Siahkali, Nazanin; Stana, Markus; Beheshti, Mohsen; Ruznic, Elvis; Iskakova, Zarina; Karner, Josef; Zellinger, Barbara; Gerum, Sabine; Roeder, Falk; Pirich, Christian; Zehentmayr, Franz

Immunotherapy Improves Clinical Outcome in Kirsten Rat Sarcoma Virus-Mutated Patients with Unresectable Non-Small Cell Lung Cancer Stage III: A Subcohort Analysis of the Austrian Radio-Oncological Lung Cancer Study Association Registry (ALLSTAR)

免疫疗法改善了携带 Kirsten 大鼠肉瘤病毒突变的不可切除非小细胞肺癌 III 期患者的临床结果:奥地利放射肿瘤肺癌研究协会登记处 (ALLSTAR) 的亚组分析

Ruznic, Elvis; Klebermass, Marisa; Zellinger, Barbara; Langer, Brigitte; Grambozov, Brane; Purevdorj, Ayurzana; Karner, Josef; Gruber, Georg; Stana, Markus; Minasch, Danijela; Kirchhammer, Karoline; Steffal, Claudia; Stranzl, Heidi; Moosbrugger, Raphaela; Feurstein, Petra; Dieckmann, Karin; Zehentmayr, Franz

Single-cell profiling of alveolar rhabdomyosarcoma reveals RAS pathway inhibitors as cell-fate hijackers with therapeutic relevance

单细胞分析揭示RAS通路抑制剂作为细胞命运劫持者具有治疗意义,可用于治疗肺泡横纹肌肉瘤。

Sara G Danielli ,Ermelinda Porpiglia ,Andrea J De Micheli ,Natalia Navarro ,Michael J Zellinger ,Ingrid Bechtold ,Samanta Kisele ,Larissa Volken ,Quy A Ngo ,Joana G Marques ,Stephanie Kasper ,Peter K Bode ,Anton G Henssen ,Dennis Gürgen ,Olivier Delattre ,Didier Surdez ,Josep Roma ,Peter Bühlmann ,Helen M Blau ,Marco Wachtel ,Beat W Schäfer

The Coronavirus Disease 2019 Pandemic Impacts Burnout Syndrome Differently Among Multiprofessional Critical Care Clinicians-A Longitudinal Survey Study

2019冠状病毒病大流行对多学科重症监护临床医生倦怠综合征的影响存在差异——一项纵向调查研究

Moll, Vanessa; Meissen, Heather; Pappas, Sharon; Xu, Kejun; Rimawi, Ramzy; Buchman, Timothy G; Fisher, Lisa; Bakshi, Vishal; Zellinger, Mary; Coopersmith, Craig M

EGFR Amplification Is a Phenomenon of IDH Wildtype and TERT Mutated High-Grade Glioma: An Integrated Analysis Using Fluorescence In Situ Hybridization and DNA Methylome Profiling

EGFR扩增是IDH野生型和TERT突变型高级别胶质瘤的一种现象:基于荧光原位杂交和DNA甲基化组分析的综合研究

Hölzl, Dorothee; Hutarew, Georg; Zellinger, Barbara; Alinger-Scharinger, Beate; Schlicker, Hans U; Schwartz, Christoph; Sotlar, Karl; Kraus, Theo F J

Preface for Brain Tumor Pathology vol. 39 issue 2: (Special issue for the 39th Annual Meeting of the Japan Society of Brain Tumor Pathology)

《脑肿瘤病理学》第39卷第2期序言:(日本脑肿瘤病理学会第39届年会特刊)

Kraus, Theo F J; Schwartz, Christoph; Machegger, Lukas; Zellinger, Barbara; Hölzl, Dorothee; Schlicker, Hans U; Pöppe, Johannes; Ladisich, Barbara; Spendel, Mathias; Kral, Michael; Sotlar, Karl; Takeshima, Hideo

Fatal course of undetected Ewing-like sarcoma in a 9-year-old boy with uncharacteristic clinical presentation

一名9岁男孩因未被发现的尤文氏肉瘤样病变而死亡,该男孩临床表现异常。

Gotsmy, Walther; Neumayer, Bettina; Kraus, Theo; Zellinger, Barbara; Neureiter, Daniel; Monticelli, Fabio; Meyer, Harald; Hofer, Peter

Integrated analysis of programmed cell death ligand 1 expression reveals increased levels in high-grade glioma

对程序性死亡配体1表达的综合分析显示,高级别胶质瘤中其水平升高。

Hölzl, Dorothee; Hutarew, Georg; Zellinger, Barbara; Schlicker, Hans U; Schwartz, Christoph; Winkler, Peter A; Sotlar, Karl; Kraus, Theo F J